Iovance Stock Been Hammered: A Buying Opportunity or Lure for Risky Bets
Iovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
We review the 2024 average FICO score, what it implies for loan pricing, and practical steps to improve beyond the average.
8,903 articlesIovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Progressive has surged to the top of private auto insurance, outpacing rivals and growing policy counts. This deep di...
Two very different players dominate the modern financial scene: Ally Financial builds on auto lending with a growing ...
A director quietly sold a notable stake in American Superconductor, prompting questions about what it signals for inv...
Investors often chase the 'smartest' stock, but in defense, the best move is a disciplined plan. This article breaks ...
Hydrogen stocks have teased a breakthrough for years. This article weighs the possibility that could this hydrogen st...
A low annual fee travel card can unlock meaningful travel rewards without the cost of premium options. This guide bre...
A famous value investor bets against Caterpillar as the AI infrastructure trend lifts the stock. Market watchers weig...
A thoughtful tribute to a public figure whose approach to tax policy blends discipline with cooperation. This piece p...
A new global liveability ranking places a major city at the bottom in 2026, triggering concerns about investment, hou...
A founder sold a meaningful chunk of stock, but does that signal trouble or a routine liquidity move? This article br...
In the first half of 2026, here's plug power stock surged 37.6%, signaling a renewed optimism around hydrogen fuels a...